Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alloy Therapeutics
Biotech
Biogen links up with Alloy platform to boost ASO drug development
The agreement allows Biogen to apply the platform to advance antisense therapeutics against multiple undisclosed targets.
Will Maddox
Apr 7, 2026 6:00am
Bayer radiology head takes top U.S. pharma spot—Chutes & Ladders
Apr 3, 2026 8:30am
Former Roche oncology head turns to Tubulis—Chutes & Ladders
Jan 9, 2026 8:30am
Sanofi inks $400M biobucks deal for Alloy's antisense platform
Jan 8, 2025 5:08am
Abbvie's president adds COO title—Chutes & Ladders
Jun 30, 2023 9:30am
New JV from Pyxis, Alloy aims for rapid drug development
May 25, 2021 10:00am
